Folgen
R.J. Seager
R.J. Seager
OmniSeq, Inc.
Bestätigte E-Mail-Adresse bei omniseq.com
Titel
Zitiert von
Zitiert von
Jahr
Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression
RJ Seager, C Hajal, F Spill, RD Kamm, MH Zaman
Convergent science physical oncology 3 (3), 034002, 2017
1392017
Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment
SWL Lee, RJ Seager, F Litvak, F Spill, JL Sieow, PH Leong, D Kumar, ...
Integrative Biology 12 (4), 90-108, 2020
542020
Solid dissolution in a fluid solvent is characterized by the interplay of surface area-dependent diffusion and physical fragmentation
RJ Seager, AJ Acevedo, F Spill, MH Zaman
Scientific reports 8 (1), 7711, 2018
522018
Visceral obesity promotes lung cancer progression—toward resolution of the obesity paradox in lung cancer
J Barbi, SK Patnaik, S Pabla, R Zollo, RJ Smith Jr, SN Sass, A Srinivasan, ...
Journal of Thoracic Oncology 16 (8), 1333-1348, 2021
362021
A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors
JM Conroy, S Pabla, ST Glenn, RJ Seager, E Van Roey, S Gao, ...
Plos one 16 (12), e0260089, 2021
232021
Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response
S Pabla, RJ Seager, E Van Roey, S Gao, C Hoefer, MK Nesline, ...
Biomarker Research 9 (1), 56, 2021
232021
Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression. Converg Sci Phys Oncol. 2017; 3: 034002
RJ Seager, C Hajal, F Spill, RD Kamm, MH Zaman
Journal of Immunology Research 3046379, 2019
112019
Obesity-Specific Association of Statin Use and Reduced Risk of Recurrence of Early Stage NSCLC
SK Patnaik, C Petrucci, J Barbi, RJ Seager, S Pabla, S Yendamuri
JTO Clinical and Research Reports 2 (12), 100254, 2021
52021
Risk analysis of the residual heat removal system at south Texas project with a special focus on breach of containment
M Solom, C Chance, C Pannier, R Seager, A Lee, J Green, T Duong, ...
International Conference on Nuclear Engineering 44960, 321-331, 2012
42012
Antimicrobial resistance trends from a hospital and diagnostic facility in Lahore, Pakistan: A five-year retrospective analysis (2014-2018)
C Ching, S Nizamuddin, F Rasheed, RJ Seager, F Litvak, F Sultan, ...
medRxiv, 19012617, 2019
32019
Visceral obesity in non-small cell lung cancer
L Nitsche, Y Vedire, E Kannisto, X Wang, RJ Seager, S Pabla, SK Patnaik, ...
Cancers 14 (14), 3450, 2022
22022
Cancer testis antigen burden: A novel predictive biomarker for immunotherapy in solid tumors
S Pabla, RJ Seager, YH Lee, E Van Roey, S Gao, V Giamo, B Burgher, ...
Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021
22021
LAG3 landscape in solid tumors and its association with immunotherapy outcomes in non-small cell lung cancer.
R Seager, MF Senosain, E Van Roey, S Gao, P DePietro, MK Nesline, ...
Journal of Clinical Oncology 41 (16_suppl), e21113-e21113, 2023
12023
77 Prevalence of secondary immunotherapeutic targets in the absence of established immune biomarkers in solid tumors
P DePietro, M Nesline, YH Lee, RJ Seager, E Van Roey, S Gao, V Giamo, ...
Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A86-A86, 2021
12021
SO-5 Tumor inflammation and proliferative status as biomarkers in gastroesophageal adenocarcinoma
S Mukherjee, R Seager, Y Lee, J Conroy, S Pabla
Annals of Oncology 32, S204, 2021
12021
Antimicrobial resistance trends from a hospital and diagnostic facility in Lahore, Pakistan: 6 A five-year retrospective analysis (2014-2018) 7
C Ching, S Nizamuddin, F Rasheed, RJ Seager, F Litvak, F Sultan, ...
1
Synergistic interactions between TGF-β1-and TNFα-induced signaling in cancer cells are the result of TAK1-and Smad7-mediated crosstalk
RJ Seager, F Spill, R Li, RD Kamm, MH Zaman
review, 0
1
Abstract PO5-06-09: Metastatic triple negative breast cancer has distinct tumor immune landscape
R Seager, H Ko, S Pabla, MF Senosain, E Van Roey, S Gao, K Strickland, ...
Cancer Research 84 (9_Supplement), PO5-06-09-PO5-06-09, 2024
2024
Abstract PO4-25-03: Comprehensive immune profiling reveals factors associated with neoadjuvant chemotherapy response in triple negative breast cancer
R Seager, H Ko, S Pabla, MF Senosain, P Kalinski, E Van Roey, S Gao, ...
Cancer Research 84 (9_Supplement), PO4-25-03-PO4-25-03, 2024
2024
Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer
RJ Seager, H Ko, S Pabla, MF Senosain, P Kalinski, E Van Roey, S Gao, ...
Journal of Personalized Medicine 14 (5), 481, 2024
2024
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20